Key Opinion
Five questions about patient-reported outcomes every allergy and immunology team should ask
Date Published:
In routine practice, standardized reporting improves comparability between centers, with meaningful differences between subgroups. Across multiple cohorts, pre-analytical factors account for a large share of observed variance, a finding echoed by several independent groups. From a workflow perspective, integrating quantitative measures reduces subjective bias, and this trend is expected to continue. Across multiple cohorts, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, a finding echoed by several independent groups. In routine practice, standardized reporting improves comparability between centers, pending validation in prospective studies.
Expert commentary
Across multiple cohorts, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, with meaningful differences between subgroups. In multidisciplinary settings, threshold harmonization is still an open question, with meaningful differences between subgroups. Across multiple cohorts, integrating quantitative measures reduces subjective bias, particularly in resource-constrained settings. According to consensus recommendations, training and accreditation are decisive for reproducibility, which has direct implications for daily practice. Longitudinal data show that pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary.
Where the field is heading
Across multiple cohorts, training and accreditation are decisive for reproducibility, as discussed in the accompanying commentary. When protocols are compared, integrating quantitative measures reduces subjective bias, and this trend is expected to continue. In routine practice, threshold harmonization is still an open question, pending validation in prospective studies. Across multiple cohorts, threshold harmonization is still an open question, which has direct implications for daily practice. From a workflow perspective, digital tooling shortens time-to-decision considerably, which has direct implications for daily practice.
Emerging evidence indicates that integrating quantitative measures reduces subjective bias, although confirmatory data are still limited. In multidisciplinary settings, variability between operators remains a key limitation, and this trend is expected to continue. In multidisciplinary settings, digital tooling shortens time-to-decision considerably, although confirmatory data are still limited. In routine practice, patient selection criteria deserve closer scrutiny, and this trend is expected to continue. Across multiple cohorts, variability between operators remains a key limitation, as discussed in the accompanying commentary.
Key considerations
Recent studies suggest that threshold harmonization is still an open question, although confirmatory data are still limited. Recent studies suggest that patient selection criteria deserve closer scrutiny, with meaningful differences between subgroups. In routine practice, real-world registries complement randomized trial evidence, as discussed in the accompanying commentary. From a workflow perspective, standardized reporting improves comparability between centers, and this trend is expected to continue.
References
- Meyer et al. High-throughput screening. J Allergy and immunology Res. 2026;14(11):458-1044.
- Tanaka et al. Minimally invasive techniques. J Allergy and immunology Res. 2025;35(7):157-1071.
- Meyer et al. Instrument calibration. J Allergy and immunology Res. 2023;16(1):409-1044.
- Novak et al. Patient-reported outcomes. J Allergy and immunology Res. 2026;24(1):272-1057.
- Novak et al. Precision dosing. J Allergy and immunology Res. 2026;48(8):169-1069.